Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Elevated CCL2 causes Leydig cell malfunction in metabolic syndrome
Qingkui Jiang, Constanze C. Maresch, Sebastian Friedrich Petry, Agnieszka Paradowska-Dogan, Sudhanshu Bhushan, Yongsheng Chang, Christine Wrenzycki, Hans-Christian Schuppe, Petr Houska, Michaela F. Hartmann, Stefan A. Wudy, Lanbo Shi, Thomas Linn
Qingkui Jiang, Constanze C. Maresch, Sebastian Friedrich Petry, Agnieszka Paradowska-Dogan, Sudhanshu Bhushan, Yongsheng Chang, Christine Wrenzycki, Hans-Christian Schuppe, Petr Houska, Michaela F. Hartmann, Stefan A. Wudy, Lanbo Shi, Thomas Linn
View: Text | PDF
Research Article Endocrinology Reproductive biology

Elevated CCL2 causes Leydig cell malfunction in metabolic syndrome

  • Text
  • PDF
Abstract

Metabolic syndrome (MetS), which is associated with chronic inflammation, predisposes males to hypogonadism and subfertility. The underlying mechanism of these pathologies remains poorly understood. Homozygous leptin-resistant obese db/db mice are characterized by small testes, low testicular testosterone, and a reduced number of Leydig cells. Here we report that IL-1β, CCL2 (also known as MCP-1), and corticosterone concentrations were increased in the testes of db/db mice relative to those in WT controls. Cultured murine and human Leydig cells responded to cytokine stress with increased CCL2 release and apoptotic signals. Chemical inhibition of CCL2 rescued Leydig cell function in vitro and in db/db mice. Consistently, we found that Ccl2-deficient mice fed with a high-energy diet were protected from testicular dysfunction compared with similarly fed WT mice. Finally, a cohort of infertile men with a history of MetS showed that reduction of CCL2 plasma levels could be achieved by weight loss and was clearly associated with recovery from hypogonadism. Taken together, we conclude that CCL2-mediated chronic inflammation is, to a large extent, responsible for the subfertility in MetS by causing damage to Leydig cells.

Authors

Qingkui Jiang, Constanze C. Maresch, Sebastian Friedrich Petry, Agnieszka Paradowska-Dogan, Sudhanshu Bhushan, Yongsheng Chang, Christine Wrenzycki, Hans-Christian Schuppe, Petr Houska, Michaela F. Hartmann, Stefan A. Wudy, Lanbo Shi, Thomas Linn

×

Figure 7

CCL2 regulated function and apoptosis of primary human Leydig cells.

Options: View larger image (or click on image) Download as PowerPoint
CCL2 regulated function and apoptosis of primary human Leydig cells.
(A–...
(A–C) Representative pictures showing CCL2 and ILB mRNA expressions in HLC after 48 hours’ treatment with hCG in the absence or presence of IL-1β (1 ng/mL), with or without Bindarit (100 μM) (A), followed by quantification: number of CCL2 (B) and ILB (C) mRNA molecules per HLC. (D–F) Representative pictures showing CCL2 and STAR protein expressions in HLC after 48 hours’ treatment with hCG in the absence or presence of IL-1β (1 ng/mL), with or without Bindarit (100 μM) (D), followed by quantification: average fluorescence intensity of CCL2 (E) and STAR (F) per HLC. (G and H) Representative pictures showing voltage-dependent anion-selective channel 1 (VDAC-1) protein expression in HLC after 48 hours’ treatment with hCG in the absence or presence of IL-1β (1 ng/mL), with or without Bindarit (100 μM) (G), followed by quantification, average fluorescence intensity of VDAC-1 per HLC (H). Data represent at least 3 independent experimental runs. Scale bar: 10 μm. N = ~100–180 cells in each group. Data represent 1 of 3 independent experiments and are shown as means ± SEM. One-way ANOVA was used to compare means between groups followed by Tukey’s post hoc comparisons. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts